=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-05-11
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: Edwards Lifesciences Corp (EW)
CIK: 0001099800
--- Reporting Owner ---
Name: Zovighian Bernard J
CIK: 0001665141
Role: Director, Officer (CEO)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-05-11 | Code: M (Exercise of derivative)
Shares: +47,207 | Price: $0.00
Shares Owned After: 157,491.6499 | Ownership: D (Direct)
Footnotes:
[F1] On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4.
[F1] On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4.
[Transaction #2]
Security: Common Stock
Date: 2026-05-11 | Code: F (Payment of exercise/tax)
Shares: -26,198 | Price: $79.96
Total Value: $2,094,792.08
Shares Owned After: 125,804.6499 | Ownership: D (Direct)
[Transaction #3]
Security: Common Stock
Date: 2026-05-12 | Code: G (Gift)
Shares: -26,640 | Price: $0.00
Shares Owned After: 99,164.6499 | Ownership: D (Direct)
[Transaction #4]
Security: Common Stock
Date: 2026-05-12 | Code: G (Gift)
Shares: +26,640 | Price: $0.00
Shares Owned After: 48,390.5511 | Ownership: I (Indirect) | Nature: By Trust
[Transaction #5]
Security: Common Stock
Date: 2026-05-12 | Code: S (Open market sale)
Shares: -845 | Price: $78.40
Total Value: $66,250.28
Shares Owned After: 47,545.5511 | Ownership: I (Indirect) | Nature: By Trust
Footnotes:
[F2] The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
[F3] This transaction was executed in multiple trades at prices ranging from $78.390 to $78.430. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
[Transaction #6]
Security: Common Stock
Date: 2026-05-12 | Code: S (Open market sale)
Shares: -35,506 | Price: $77.92
Total Value: $2,766,762.44
Shares Owned After: 12,039.5511 | Ownership: I (Indirect) | Nature: By Trust
Footnotes:
[F2] The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
[F4] This transaction was executed in multiple trades at prices ranging from $77.375 to $78.360. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
--- Derivative Transactions ---
[Transaction #1]
Security: Performance Rights
Date: 2026-05-11 | Code: M (Exercise of derivative)
Shares: -47,207 | Price: $0.00
Shares Owned After: 0 | Ownership: D (Direct)
Footnotes:
[F1] On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4.
[F5] These Performance Rights expire on May 10, 2030.
--- Holdings ---
[Holding #1]
Security: Common Stock
Ownership: I (Indirect)
--- Footnotes (Complete Index) ---
F1: On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4.
F2: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
F3: This transaction was executed in multiple trades at prices ranging from $78.390 to $78.430. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F4: This transaction was executed in multiple trades at prices ranging from $77.375 to $78.360. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F5: These Performance Rights expire on May 10, 2030.
--- Signature ---
/s/ Linda J. Park, Attorney-in-Fact (2026-05-12)
